BLISS GVS PHARMA Quarterly Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BLISS GVS PHARMA Quarterly Results    (BLCH)

Here are the latest quarterly results of BLISS GVS PHARMA. For more details, see the BLISS GVS PHARMA financial fact sheet and BLISS GVS PHARMA share price and chart. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

BLISS GVS PHARMA Quarterly Results

No. of Mths
Qtr. Ending
3
Sep-19
*
3
Dec-19
*
3
Mar-20
*
3
Jun-20
*
3
Sep-20
*
3
Dec-20
*
3
Mar-21
*
3
Jun-21
*
8-Qtr Chart
Click to enlarge
Net Sales Rs m2,1011,4781,1981,2961,5151,6411,3211,681 
Other income Rs m129551667027416378 
Turnover Rs m2,2301,5341,3641,3661,5431,6821,3841,760 
Expenses Rs m1,8471,1491,0401,1011,1951,2581,1521,335 
Gross profit Rs m25532925195320383169346 
Depreciation Rs m3530334343444343 
Interest Rs m11112418492414 
Profit before tax Rs m338344133204301371166367 
Tax Rs m30907838849584106 
Profit after tax Rs m3092555616721627682261 
Gross profit margin %12.122.32.115.021.123.312.820.6 
Effective tax rate %8.726.058.218.428.125.750.828.8 
Net profit margin %14.717.24.712.914.316.86.215.5 
Diluted EPS Rs 3.0 2.5 0.5 1.6 2.1 2.7 0.8 2.5  
Diluted EPS (TTM) Rs NA NA 9.2 7.6 6.7 6.9 7.2 8.1  
 Subscriber Feature                  
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster

Read: BLISS GVS PHARMA 1QFY22 Result Performance Review

More Pharmaceuticals Company Quarterly Results:   HULTA PHARMA  FORTIS MALAR  ASTRAZENECA PHARMA  KOVAI MEDICAL  FERMENTA BIOTECH  

Compare BLISS GVS PHARMA With:   HULTA PHARMA  FORTIS MALAR  ASTRAZENECA PHARMA  KOVAI MEDICAL  FERMENTA BIOTECH  



Today's Market

Sensex Slumps 700 Points from Day's High to End Lower; Tata Steel & SBI Among Top Losers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended lower.

Views on news

BLISS GVS PHARMA Announces Quarterly Results (1QFY22); Net Profit Up 56.9% (Quarterly Result Update)

Aug 3, 2021 | Updated on Aug 3, 2021

For the quarter ended June 2021, BLISS GVS PHARMA has posted a net profit of Rs 261 m (up 56.9% YoY). Sales on the other hand came in at Rs 2 bn (up 29.8% YoY). Read on for a complete analysis of BLISS GVS PHARMA's quarterly results.

BLISS GVS PHARMA Announces Quarterly Results (4QFY21); Net Profit Up 46.3% (Quarterly Result Update)

Jul 9, 2021 | Updated on Jul 9, 2021

For the quarter ended March 2021, BLISS GVS PHARMA has posted a net profit of Rs 82 m (up 46.3% YoY). Sales on the other hand came in at Rs 1 bn (up 10.2% YoY). Read on for a complete analysis of BLISS GVS PHARMA's quarterly results.

5 Indian Pharma Companies Riding the Vaccination Wave (Views On News)

Sep 3, 2021

These companies are likely to benefit the most from Covid-19 vaccines.

Apollo Hospitals' Shares Rally Over 5%, Hit Record-High on Strong Results (Views On News)

Aug 16, 2021

The company reported a 73% YoY increase in revenue driven by an uptick in the hospital and pharmacy business.

J B Chemicals & Pharma's Decent Performance Puts Stock in Focus (Views On News)

Aug 13, 2021

The company seeks to expand the market for prescription lozenges with new launches this year.

More Views on News

Most Popular

Sansera Engineering IPO: Key Points to Consider (Views On News)

Sep 8, 2021

This IPO is a pure OFS and the company is looking to raise Rs 12.8 bn at the upper price band of Rs 744.

5 Stocks that Turned Rs 1 Lakh into Rs 1 Crore (Views On News)

Sep 7, 2021

Patience is one of the biggest virtues you need to have if you want to become a crorepati in the stock market.

The Top Stocks to Sell in this Bull Market (Profit Hunter)

Sep 8, 2021

When I saw the list of so-called 'value stocks' published by a leading brokerage, my worst fears came true.

5 Indian Companies that are Leading the AI Race (Views On News)

Sep 9, 2021

During the pandemic, India reported the highest increase in the use of AI at 45% compared to other major economies. AI has potential to add US$90 bn to the Indian economy by 2025.

How to Create a Second Income from Trading (Profit Hunter)

Sep 10, 2021

My trading system that works in all kinds of markets.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2021
Get our special report Multibagger Stocks Guide (2021 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

BLISS GVS PHARMA SHARE PRICE


Sep 17, 2021 (Close)

TRACK BLISS GVS PHARMA

  • Track your investment in BLISS GVS PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON BLISS GVS PHARMA

BLISS GVS PHARMA 5-YR ANALYSIS

COMPARE BLISS GVS PHARMA WITH

MARKET STATS